| KIVEXA EU/1/04/298/1-2 |
Abacavir sulfate, Lamivudine |
ViiV Healthcare BV |
— |
| Klacid 250 mg film-coated tablets PA23355/013/001 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Klacid 250 mg/5 ml Granules for Oral Suspension PA23355/013/006 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Klacid Forte 500 mg film-coated tablets PA23355/013/002 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Klacid IV 500mg Powder for Concentrate for Solution for Infusion PA23355/013/003 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Klacid LA 500mg Modified release tablets PA23355/013/004 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Klacid Paediatric Suspension 125 mg/5 ml, Granules for Oral Suspension PA23355/013/005 |
Clarithromycin |
Viatris Healthcare Limited |
Marketed |
| Kliogest 2 mg/1 mg film-coated tablets PA0218/022/001 |
Estradiol, Norethisterone acetate |
Novo Nordisk A/S |
Marketed |
| Klisyri 10 mg/g ointment EU/1/21/1558/001 |
Tirbanibulin |
Almirall, S.A. |
— |
| Kogenate Bayer EU/1/00/143/002 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/003 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/005 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/006 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/012-013 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/10-11 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| KOGENATE Bayer EU/1/00/143/001 |
Octocog alfa, R-dna (baby hamster kidney expression system) |
Bayer AG |
— |
| KOGENATE BAYER EU/1/00/143/004 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Komboglyze 2.5 mg/1000 mg film-coated tablets EU/1/11/731/007-012 |
Metformin Hydrochloride, Saxagliptin |
AstraZeneca AB |
— |
| Komboglyze 2.5 mg/850 mg film-coated tablets EU/1/11/731/001-006 |
Saxagliptin, Metformin Hydrochloride |
AstraZeneca AB |
— |
| Konakion MM Ampoules 10 mg/ml Solution for Injection and Oral Solution PA2239/002/001 |
Phytomenadione |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Konakion MM Paediatric Ampoules 2 mg/ 0.2 ml oral solution or solution for injection PA2239/002/002 |
Phytomenadione |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Konverge 20 mg/5 mg film-coated tablets PA0865/017/001 |
Olmesartan medoxomil, Amlodipine |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge 40 mg/10 mg film-coated tablets PA0865/017/003 |
Olmesartan medoxomil, Amlodipine |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge 40 mg/5 mg film-coated tablets PA0865/017/002 |
Olmesartan medoxomil, Amlodipine |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge Plus 20 mg/5 mg/12.5 mg film-coated tablets PA0865/019/001 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge Plus 40mg/10mg/12.5mg film coated tablets PA0865/019/003 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge Plus 40mg/10mg/25mg film coated tablets PA0865/019/005 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge Plus 40mg/5mg/12.5mg film coated tablets PA0865/019/002 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Konverge Plus 40mg/5mg/25mg film coated tablets PA0865/019/004 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
Menarini International Operations Luxembourg S.A. |
Marketed |
| Kopen 250mg Tablets PA1418/014/003 |
Phenoxymethylpenicillin potassium |
Athlone Pharmaceuticals Limited |
Marketed |
| Kopen Sugar Free 125 mg/5 ml Powder for Oral Solution PA1418/014/001 |
Phenoxymethylpenicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Kopen Sugar Free 250 mg/5 ml Powder for Oral Solution PA1418/014/002 |
Phenoxymethylpenicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Korjuny 10 micrograms concentrate for solution for infusion EU/1/24/1826/001 |
Catumaxomab |
Atnahs Pharma Netherlands B.V. |
— |
| Korjuny 50 micrograms concentrate for solution for infusion EU/1/24/1826/002 |
Catumaxomab |
Atnahs Pharma Netherlands B.V. |
— |
| Koselugo 10 mg hard capsules EU/1/21/1552/001 |
Selumetinib Sulfate |
AstraZeneca AB |
— |
| Koselugo 25 mg hard capsules EU/1/21/1552/002 |
Selumetinib Sulfate |
AstraZeneca AB |
— |
| Kostaive powder for dispersion for injection. COVID-19 sa-mRNA Vaccine EU/1/24/1873/001 |
Zapomeran |
Arcturus Therapeutics Europe B.V. |
— |
| Kovaltry 1000 IU powder and solvent for solution for injection EU/1/15/1076/006 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 2000 IU powder and solvent for solution for injection EU/1/15/1076/008 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 250 IU powder and solvent for solution for injection EU/1/15/1076/002 |
Octocog alfa |
Bayer AG |
— |
| Kovaltry 3000 IU powder and solvent for solution for injection EU/1/15/1076/010 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 500 IU powder and solvent for solution for injection EU/1/15/1076/004 |
Octocog alfa |
Bayer Pharma AG |
— |
| KRAZATI 200 mg film-coated tablets EU/1/23/1744/001-002 |
Adagrasib |
Bristol-Myers Squibb Pharma EEIG |
— |
| KryptoScan, [81m Kr] Radionuclide generator PA0690/007/001 |
Krypton (81m kr) |
Curium Netherlands B.V. |
Not marketed |
| Kuvan 100 mg powder for oral solution EU/1/08/481/004 |
Sapropterin hydrochloride |
Biomarin International Limited |
— |
| Kuvan 100 mg soluble tablets EU/1/08/481/1-3 |
Sapropterin dihydrochloride |
Biomarin International Limited |
— |
| Kuvan 500 mg powder for oral solution EU/1/08/481/005 |
Sapropterin hydrochloride |
Biomarin International Limited |
— |
| Kwells 300 microgram Tablets PA2261/006/001 |
Hyoscine hydrobromide |
Dexcel Pharma GmbH |
Marketed |
| Kyleena 19.5 mg intrauterine delivery system PA1410/081/001 |
Levonorgestrel |
Bayer Limited |
Marketed |
| Kyleena 19.5 mg intrauterine delivery system PPA1463/186/001 |
Levonorgestrel |
IMED Healthcare Ltd., |
— |